vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.
MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). MID PENN BANCORP INC runs the higher net margin — 31.4% vs -4.8%, a 36.1% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $71.8M). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
IRWD vs MPB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $62.0M |
| Net Profit | $-2.3M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 43.6% |
| Net Margin | -4.8% | 31.4% |
| Revenue YoY | -47.3% | 30.8% |
| Net Profit YoY | -200.9% | 47.0% |
| EPS (diluted) | $0.01 | $0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $62.0M | ||
| Q3 25 | $122.1M | $61.8M | ||
| Q2 25 | $85.2M | $54.3M | ||
| Q1 25 | $41.1M | $47.7M | ||
| Q4 24 | $90.5M | $47.4M | ||
| Q3 24 | $91.6M | $45.3M | ||
| Q2 24 | $94.4M | $44.1M | ||
| Q1 24 | $74.9M | $42.3M |
| Q4 25 | $-2.3M | $19.4M | ||
| Q3 25 | $40.1M | $18.3M | ||
| Q2 25 | $23.6M | $4.8M | ||
| Q1 25 | $-37.4M | $13.7M | ||
| Q4 24 | $2.3M | $13.2M | ||
| Q3 24 | $3.6M | $12.3M | ||
| Q2 24 | $-860.0K | $11.8M | ||
| Q1 24 | $-4.2M | $12.1M |
| Q4 25 | 14.3% | 43.6% | ||
| Q3 25 | 61.8% | 39.3% | ||
| Q2 25 | 53.2% | 7.9% | ||
| Q1 25 | -70.7% | 35.2% | ||
| Q4 24 | 34.8% | 34.1% | ||
| Q3 24 | 28.0% | 32.8% | ||
| Q2 24 | 26.5% | 32.4% | ||
| Q1 24 | 14.7% | 34.8% |
| Q4 25 | -4.8% | 31.4% | ||
| Q3 25 | 32.8% | 29.6% | ||
| Q2 25 | 27.7% | 8.8% | ||
| Q1 25 | -90.9% | 28.8% | ||
| Q4 24 | 2.5% | 27.9% | ||
| Q3 24 | 4.0% | 27.1% | ||
| Q2 24 | -0.9% | 26.7% | ||
| Q1 24 | -5.6% | 28.7% |
| Q4 25 | $0.01 | $0.83 | ||
| Q3 25 | $0.23 | $0.79 | ||
| Q2 25 | $0.14 | $0.22 | ||
| Q1 25 | $-0.23 | $0.71 | ||
| Q4 24 | $0.03 | $0.72 | ||
| Q3 24 | $0.02 | $0.74 | ||
| Q2 24 | $-0.01 | $0.71 | ||
| Q1 24 | $-0.03 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $814.1M |
| Total Assets | $396.9M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $814.1M | ||
| Q3 25 | $-264.2M | $796.3M | ||
| Q2 25 | $-308.2M | $775.7M | ||
| Q1 25 | $-334.1M | $667.9M | ||
| Q4 24 | $-301.3M | $655.0M | ||
| Q3 24 | $-311.3M | $573.1M | ||
| Q2 24 | $-321.7M | $559.7M | ||
| Q1 24 | $-330.5M | $551.0M |
| Q4 25 | $396.9M | $6.1B | ||
| Q3 25 | $396.1M | $6.3B | ||
| Q2 25 | $342.9M | $6.4B | ||
| Q1 25 | $327.2M | $5.5B | ||
| Q4 24 | $350.9M | $5.5B | ||
| Q3 24 | $389.5M | $5.5B | ||
| Q2 24 | $395.6M | $5.4B | ||
| Q1 24 | $438.8M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $80.0M |
| Free Cash FlowOCF − Capex | $74.6M | $71.8M |
| FCF MarginFCF / Revenue | 156.3% | 115.8% |
| Capex IntensityCapex / Revenue | 0.0% | 13.3% |
| Cash ConversionOCF / Net Profit | — | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $132.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $80.0M | ||
| Q3 25 | $47.6M | $26.3M | ||
| Q2 25 | $-15.1M | $29.0M | ||
| Q1 25 | $20.0M | $11.5M | ||
| Q4 24 | $15.2M | $51.4M | ||
| Q3 24 | $9.9M | $16.9M | ||
| Q2 24 | $33.5M | $18.0M | ||
| Q1 24 | $45.0M | $12.4M |
| Q4 25 | $74.6M | $71.8M | ||
| Q3 25 | $47.6M | $24.3M | ||
| Q2 25 | $-15.1M | $27.2M | ||
| Q1 25 | $19.9M | $8.8M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | $9.9M | $16.8M | ||
| Q2 24 | $33.4M | $17.7M | ||
| Q1 24 | $44.9M | $12.1M |
| Q4 25 | 156.3% | 115.8% | ||
| Q3 25 | 39.0% | 39.4% | ||
| Q2 25 | -17.7% | 50.1% | ||
| Q1 25 | 48.4% | 18.4% | ||
| Q4 24 | — | 93.8% | ||
| Q3 24 | 10.8% | 37.1% | ||
| Q2 24 | 35.4% | 40.2% | ||
| Q1 24 | 60.0% | 28.5% |
| Q4 25 | 0.0% | 13.3% | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.1% | 5.7% | ||
| Q4 24 | 0.0% | 14.6% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.7% | ||
| Q1 24 | 0.1% | 0.8% |
| Q4 25 | — | 4.12× | ||
| Q3 25 | 1.19× | 1.44× | ||
| Q2 25 | -0.64× | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | 6.74× | 3.88× | ||
| Q3 24 | 2.71× | 1.37× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | — | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
